- Home
- ASND vs EQH Comparison
ASND vs EQH Comparison
Compare ASND & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASND | EQH |
|---|---|---|
| Founded | 2006 | 1859 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 13.3B |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ASND | EQH |
|---|---|---|
| Price | $243.54 | $52.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 12 |
| Target Price | ★ $306.03 | $64.00 |
| AVG Volume (30 Days) | 683.6K | ★ 2.3M |
| Earning Date | 11-11-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | N/A | ★ $11,665,000,000.00 |
| Revenue This Year | $90.81 | $33.37 |
| Revenue Next Year | $46.89 | $10.31 |
| P/E Ratio | ★ N/A | $109.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $188.07 | $35.20 |
| 52 Week High | $282.15 | $55.23 |
Technical Indicators
Market Signals| Indicator | ASND | EQH |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 47.59 |
| Support Level | $242.17 | $49.86 |
| Resistance Level | $249.89 | $53.32 |
| Average True Range (ATR) | 6.21 | 1.47 |
| MACD | 2.90 | -0.02 |
| Stochastic Oscillator | 97.35 | 51.82 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
About EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.